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ABSTRACT: Syringaresinol was synthesized in a one-pot conversion
containing eugenol oxidase (EUGO) and horseradish peroxidase (HRP)
using the relatively cheap 2,6-dimethoxy-4-allylphenol as a substrate. This
conversion is fully coupled as the hydrogen peroxide generated from the
reaction of EUGO with the substrate is utilized by the HRP to convert the
formed sinapyl alcohol into syringaresinol. To improve the performance of
EUGO on 2,6-dimethoxy-4-allylphenol, structure-inspired enzyme engineer-
ing was performed. This yielded the I427A EUGO mutant that is
signiﬁcantly more eﬃcient with 2,6-dimethoxy-4-allylphenol. The I427A
EUGO mutant together with HRP were capable of eﬃciently producing
syringaresinol as a major product. After optimization and upscaling the
conversion to a semipreparative scale (1 gr), syringaresinol was obtained in
81% yield.
KEYWORDS: syringaresinol, (per)oxidase, one-pot, enzyme engineering, enzyme cascade
One-pot enzymatic cascades have received an increasingattention over recent years.1,2 Such approaches are
attractive as they save time, money, and energy needed to
make or isolate compounds with a high degree of purity and
quality.3 These cascades also allow conversions in which labile
intermediates can be used. One-pot cascades have involved a
wide range of enzymes ranging from but not exclusive to
dehydrogenases, transaminases, Baeyer−Villiger monooxyge-
nases, and oxidases.2−5 Recently, we published a one-pot two-
enzyme cascade conversion utilizing an oxidase and a
peroxidase to convert eugenol into lignin-like oligomers.6 The
diversity of enzymes used in one-pot reactions has added to the
value of this approach to synthesize various chiral compounds
and other compounds which are diﬃcult to be produced by
conventional chemical means.
In this paper, the synthesis of syringaresinol (3) in a one-pot
two-enzyme conversion is described (see Scheme 1).
Syringaresinol (3) is a lignan formed from two sinapyl alcohol
(2) units linked via a β−β linkage. The lignan is known to
display various interesting bioactivity properties. It inhibits the
motility of Helicobacter pylori in the stomach thus playing a role
in protection from gastric cancer.7 It has also been found to
help in the healing of wounds when present as a glucoside.8,9
Chung and co-workers displayed the eﬀect of syringaresinol (3)
in increasing the production of nitric oxide from nitric oxide
synthase and its complementary eﬀect on vasorelaxation of
blood vessels.10 Syringaresinol is a very rigid compound due to
the presence of a cis-fused bis-furanic moiety in its structure.
This makes it an attractive candidate for use as a substitute for
bisphenol A in industrial resins.11,12
Despite being available naturally in plants, syringaresinol is
isolated from natural sources in a very low yield.8 Chemical
synthesis of syringaresinol has achieved yields reaching 67%
through copper catalysis. However, these methods are
problematic with regard to the toxicity of the chemicals used
and the costs of the various puriﬁcation steps involved.10 The
biocatalytic synthesis of syringaresinol from sinapyl alcohol has
been described recently using a laccase from Trametes versicolor
producing the lignan in a yield of 93% in one step.8 This
method is very eﬃcient in a multigram scale, yet, concern
should be taken to the price of the starting material, sinapyl
alcohol.
Inspired by the approach in which sinapyl alcohol is
converted into syringaresinol, we designed a two-step one-pot
conversion starting from the relatively cheap 2,6-dimethoxy-4-
allylphenol. This allylphenol was shown to be a substrate for
eugenol oxidase (EUGO) by which it is converted into sinapyl
alcohol. Except for sinapyl alcohol, hydrogen peroxide is also
formed upon conversion by EUGO. This prompted us to
choose a peroxidase to perform the oxidative coupling of the
formed sinapyl alcohol. The advantage of this system is that the
hydrogen peroxide generated by EUGO is utilized directly by
the peroxidase. While EUGO is the only known oxidase capable
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to convert 2,6-dimethoxy-4-allylphenol into sinapyl alcohol, the
activity is relatively low when compared with other substrates,
such as eugenol, vanillyl alcohol and 4-(hydroxy-1-ethyl)-2-
methoxyphenol.13,14 Analysis of the structure of EUGO
suggests that the active site of the enzyme has limited space
for accommodating the two methoxy groups in the substrate.
In order to optimize the eﬃciency of the cascade conversion,
the activity of EUGO on 2,6-dimethoxy-4-allylphenol was
optimized by performing structure-inspired mutagenesis to
create a larger active site. The generated mutant EUGO was
used with horseradish peroxidase (HRP) for the eﬃcient
conversion of 2,6-dimethoxy-4-allylphenol into syringaresinol
in high yield.
EUGO was previously shown to exhibit activity with
dimethoxy-substituted phenolic substrates as opposed to
other enzymes having a similar structure.13 The main reason
for this unique property seems to come from the fact that
EUGO has a glycine at position 392, making suﬃcient room for
a second methoxy moiety on the phenolic substrate. Still,
EUGO displays a higher activity on phenolic substrates that
carry only one or no methoxy substituent. Inspection of the
isoeugenol-complexed crystal structure of EUGO (PDB:
5FXD) suggested several residues that may hamper binding
of the second methoxy moiety: Ile427 and Val166. Other
residues that are in the same area (Tyr91, Tyr471, and Arg472)
were not considered as targets for mutagenesis because they
have a role in arranging a proper interaction with the 4-hydroxy
group of the substrate. In fact, these latter three amino acids are
involved in the stabilization of the phenolate form of the
substrate and therefore play a role in forming the quinone
methide intermediate (see Figure 1).13 In order to accom-
modate two methoxy groups in the substrate binding pocket,
several Ile427 and Val166 mutants were prepared: I427V,
I427A, I427G, and V166A. By introducing relatively small
residues, more eﬃcient binding of the target substrate may be
achieved.
The steady state kinetics for the conversion of 2,6-
dimethoxy-4-allylphenol (1) for each of the three diﬀerent
Ile427 mutants revealed that the most active mutant was the
I427A (kcat = 0.72 s
−1, Km = 0.46 μM). This mutant enzyme
displays a more than 2-fold higher kcat when compared with the
wild type enzyme while also the apparent aﬃnity (Km)
decreased (wt-EUGO: kcat = 0.37 s
−1, Km = 0.77 μM). The
other two mutants also displayed improved kinetic parameters
(I427V: kcat = 0.59 s
−1, Km = 0.34 μM, I427G: kcat = 0.59 s
−1,
Km = 0.39 μM). Yet, the I427G mutant suﬀered from substrate
inhibition at elevated substrate concentrations. The V166A
mutant displayed a somewhat lower Km but also a reduced
activity when compared with wild type EUGO (V166A: kcat =
0.124 s−1, Km = 0.39 μM). The steady-state kinetic data for all
above-mentioned enzymes are shown in Figure S1. Due to its
superior kinetic properties, EUGO I427A was used to explore
its use as biocatalyst for producing sinapyl alcohol.
Sinapyl alcohol is a relatively expensive compound, whereas
2,6-dimethoxy-4-allylphenol (1), its precursor in this study, is
several orders of magnitude cheaper. This is probably due to
the fact that (1) and other 4-allylphenols can be readily isolated
from herbs and spices. This makes it attractive to explore the
use of 2,6-dimethoxy-4-allylphenol as a starting material to
prepare high-value compounds, such as sinapyl alcohol. We ﬁrst
studied the conversion of 2,6-dimethoxy-4-allylphenol into
sinapyl alcohol using EUGO I427A. When 0.5 μM of EUGO
I427A was used in the conversion, incomplete conversion of
2,6-dimethoxy-4-allylphenol to sinapyl alcohol was seen (data
not shown). It was found that EUGO I427A was capable of
completely converting 2,6-dimethoxy-4-allylphenol into sinapyl
alcohol within 22 h when 5 μM of the enzyme was added to a
Scheme 1. Conversion of 2,6-Dimethoxy-4-allylphenol (1) to Sinapyl Alcohol (2) Using EUGO and Sinapyl Alcohol to
Syringaresinol (3) Using HRP
Figure 1. Active site of EUGO with the ﬂavin cofactor (yellow), a
docked 2,6-dimethoxy-4-allylphenol (green) and highlighting residues
(cyan): Tyr91, Tyr471, and Arg472, essential for stabilization of the
phenolate form of the bound substrate, and Ile427 and Val166 that
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solution containing 10 mM of the substrate. No other products
could be detected (see Figure S2).
After having established that EUGO I427A can be used to
produce sinapyl alcohol, a cascade reaction that included the
oxidase and HRP was investigated. Incubation of 2,6-
dimethoxy-4-allylphenol with EUGO I427A and HRP in one-
pot resulted in formation of one major soluble product:
syringaresinol, a dimer of two sinapyl alcohol monomers linked
to each other through a β−β linkage. When EUGO I427A (5
μM) and HRP (0.65 μM) were added to a reaction containing
10 mM 2,6-dimethoxy-4-allylphenol, complete conversion of
2,6-dimethoxy-4-allylphenol to racemic syringaresinol as a
major product was achieved after 25 h (see Figure S3). The
reaction proceeds through the formation of sinapyl alcohol by
oxidation of 2,6-dimethoxy-4-allylphenol by EUGO, whereas, in
a second step, HRP utilizes the hydrogen peroxide that is
generated to form a free radical from the formed sinapyl
alcohol. Through dimerization of the formed radicals,
syringaresinol is formed. Though it is known that HRP can
be inactivated by hydrogen peroxide, the in situ production of
the cosubstrate prevented accumulation of excessive hydrogen
peroxide limiting this inactivation eﬀect. 2,6-Dimethoxy-4-
allylphenol is a unique substrate as both the 2- and 6-positions
are blocked by methoxy-groups for alternative coupling
reactions. This hinders the ability to form other linkages that
are characteristic of lignin polymers, as found when using
eugenol as a precursor in a EUGO/HRP-catalyzed reaction.8
The two methoxy moieties direct the reaction toward formation
of the dimerized oxidation product from sinapyl alcohol.
Some insoluble product was also formed in the reaction
above, which was isolated and analyzed separately. GPC
analysis of the material showed that the insoluble product
consisted of higher molecular weight material, in the range of
oligomers with a length of 2−10 aromatic units (see Figure S4,
Mn = 600, Mw = 750, d = 1.24). Analysis by 2D HSQC and 2D
HMBC nuclear magnetic resonance (NMR) revealed major
signals that can be ascribed to syringaresinol as well as to 2,6-
dimethoxy-4-allylphenol units (Figures S5 and S6). Unlike our
previously reported work on eugenol, no clear lignin type
linkages were detected using 2,6-dimethoxy-4-allylphenol as a
substrate apart from the β−β linkages from syringaresinol. A
signal for a β-O-4 linkage that has been modiﬁed on the α-
position could be observed; however, the exact nature of this β-
O-4 type linkage or other connectivity of the aromatic units
remains unclear. Overall, it seems that the conversion of 2,6-
dimethoxy-4-allylphenol by this enzyme cascade has a high
preference for the formation of β−β dimers over typical β-O-4
type linkages.
After testing the conversion of 2,6-dimethoxy-4-alllylphenol
to syringaresinol on a small scale, a one gram conversion was
performed. The conversion was done in a 250 mL reaction
volume using 5% dimethylsulfoxide (DMSO, v/v) as a
cosolvent. After high-performance liquid chromatography
(HPLC) analysis conﬁrmed complete conversion of the starting
material, the product was isolated from the solution by ethyl
acetate extraction and puriﬁed by column chromatography. The
whole conversion was completed in 22 h and resulted in a yield
of 870 mg (81%) syringaresinol from 1 g of the starting
material. The isolated syringaresinol appeared as pale yellow
crystals. Figure S7 shows the 1H NMR and 13C NMR spectra
for the isolated lignan. In addition to the syringaresinol, ≈80
mg of insoluble product was formed.
We have successfully been able to produce syringaresinol in a
high yield from a relatively cheap precursor in a facile one-pot
two-enzyme conversion. For this, ﬁrst the performance of the
required oxidase was successfully optimized through site-
directed mutagenesis of EUGO to improve its acceptance of
2,6-dimethoxy-4-allylphenol as a substrate. The combined use
of EUGO I427A and HRP resulted in full conversion of 2,6-
dimethoxy-4-allylphenol and formation of syringaresinol as
major product. The lignan was puriﬁed (81% yield) after a 1 g
scale conversion and analyzed using both 1H NMR and 13C
NMR to conﬁrm its purity. This newly developed biocatalytic
system for synthesis of syringaresinol could serve as a good
source for producing this medically and industrially important
compound on a large scale.
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M. W. A Biocatalytic One-Pot Approach for the Preparation of Lignin
Oligomers using an Oxidase/Peroxidase Cascade Enzyme System. Adv.
Synth. Catal. 2017, 359, 3354−3361.
(7) Fujikawa, T.; Yamaguchi, A.; Morita, I.; Takeda, H.; Nishibe, S.
Protective Effects of Acanthopanax senticosus HARMS from Hokkaido
and Its Components on Gastric Ulcer in Restrained Cold Water
Stressed Rats. Biol. Pharm. Bull. 1996, 19, 1227−1230.
(8) Jaufurally, A. S.; Teixeira, A. R. S.; Hollande, L.; Allais, F.; Ducrot,
P.-H. Optimization of the Laccase-Catalyzed Synthesis of (±)-Sy-
ringaresinol and Study of Its Thermal and Antiradical Activities.
ChemistrySelect 2016, 1, 5165−5171.
(9) Semenov, A. A.; Enikeev, A. G.; Khobrakova, V. B.; Razuvayeva,
Y. G.; Nikolayev, S. M. Study on the Healing Effect of Syringaresinol
β-D - Monoglucoside. Int. J. Biomed. 2013, 3, 287−290.
(10) Chung, B. H.; Kim, S.; Kim, J. D.; Lee, J. J.; Baek, Y. Y.; Jeoung,
D.; Lee, H.; Choe, J.; Ha, K. S.; Won, M. H.; Kwon, Y. G.; Kim, Y. M.
Syringaresinol Causes Vasorelaxation by Elevating Nitric Oxide
Production through the Phosphorylation and Dimerization of
Endothelial Nitric Oxide Synthase. Exp. Mol. Med. 2012, 44, 191−201.
(11) Janvier, M.; Hollande, L.; Jaufurally, A. S.; Pernes, M.; Meńard,
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